Europe

Seven U.K. research councils collaborate on antimicrobial resistance

Thursday, July 17, 2014 12:50 PM

The Medical Research Council (MRC) will lead an initiative of seven research councils, backed by eight government bodies and the Wellcome Trust, to tackle antimicrobial resistance (AMR) on all fronts. The seven research councils are the Arts and Humanities Research Council, Biotechnology and Biological Sciences Research Council, Economic and Social Research Council, Engineering and Physical Sciences Research Council, MRC, Natural Environment Research Council and Science and Technology Facilities Council.

More... »


Report: U.K. cancer patients face increasing coverage restrictions

Wednesday, July 16, 2014 01:18 PM

New research results quantify the extent to which centralized value assessments by the U.K.’s National Institute for Health and Care Excellence (NICE) lead to coverage denials and patient access restrictions to new drugs and biologics. The analysis, conducted by Context Matters, a healthcare information and data analytics technology platform company, and sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA), shows use of centralized cost-effectiveness standards by NICE and similar appraisals in other countries limit patients’ access to new cancer treatments, which evolve rapidly and are increasingly personalized. 

More... »


Analysis finds NHS could experience funding crisis before general election

Friday, July 11, 2014 11:26 AM

According to the Nuffield Trust, the NHS is poorly placed to deal with continuing austerity and could experience a funding crisis before the 2015 General Election. A new panel of 100 health and social care leaders also have raised concerns about the future sustainability of the NHS and social care. The Nuffield Trust’s Health and Social Care Leaders’ panel is a survey of NHS and social care professionals' views on the NHS and the social care system in England, and how it should be developed beyond the 2015 general election.  

More... »

EMA recommends 39 medicines for marketing authorization in first half of 2014

Friday, July 11, 2014 11:25 AM

Thirty-nine medicines for human use were recommended for marketing authorization by the EMA’s Committee for Medicinal Products for Human Use (CHMP) in the first half of 2014, compared with 44 in first half of 2013 and 33 in first half of 2012.

More... »

EMA’s clinical trial data policy delayed until October

Thursday, July 10, 2014 12:53 PM

The management board of the EMA has postponed formal adoption of the policy on publication of clinical trial data until its Oct. 2 meeting. Further clarifications on wording and practical arrangements will be discussed by board members, who have confirmed their general support of the overall aim and objectives of the policy, including the more user-friendly amendments proposed by Guido Rasi, EMA executive director, that would allow data to be downloaded, saved or printed for academic and non-commercial research purposes.

More... »

Prescriptions in England up 60%, but costs up only 15% since 2003

Wednesday, July 9, 2014 12:10 PM

The number of prescription items dispensed in England has increased by 58.5% since 2003, according to a new Health and Social Care Information Center (HSCIC) analysis. Over 1.03 billion items were prescribed in 2013, compared to 649.7 million in 2003.

More... »

EFPIA launches IMI2—a $4.5B public-private healthcare partnership

Wednesday, July 9, 2014 12:09 PM

EFPIA has announced the launch of IMI2, the continuation of the successful partnership of industry and public bodies to tackle health needs. IMI is a public-private partnership (PPP) between the European Commission and EFPIA, the European Federation of Pharmaceutical Industries and Associations. The first phase of IMI (2008 to 2013) was established with a budget of $2.7 billion. IMI2 has been established under the E.U. framework program Horizon 2020 with an even bigger budget of $4.5 billion—bringing together the public and private sectors in the largest healthcare PPP in Europe.

More... »

U.K. Prime Minister commissions independent antibiotics review

Wednesday, July 2, 2014 12:48 PM

U.K. Prime Minister David Cameron, along with the U.K. Department of Health, has commissioned a wide reaching independent review, led by economist Jim O’Neill and co-funded and hosted by medical research foundation the Wellcome Trust, to explore the economic issues surrounding antimicrobial resistance. Growing numbers of bacterial and viral infections are resistant to antimicrobial drugs, but no new classes of antibiotics have come on the market for more than 25 years.

More... »

ACRP, European Center for Clinical Research Training collaborate

Thursday, June 19, 2014 01:45 PM

The Association of Clinical Research Professionals (ACRP) and the European Center for Clinical Research Training (ECCRT), a SynteractHCR company, have introduced the ECCRT/ACRP STAR Program, a comprehensive and collaborative clinical research training and development program being offered across Europe.

More... »

Medical Research Council launches U.K. Dementias Research Platform

Thursday, June 19, 2014 01:39 PM

The Medical Research Council (MRC) has launched the U.K. Dementias Research Platform (UKDP), a $27.2 million public-private partnership set up to speed up research into dementias. The collaboration aims to enable earlier detection, improved treatment and, ultimately, prevention of the disease by looking not just at what is going wrong in the brain, but at the brain in the context of the whole body.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 15

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Five southern research groups form public-private network to help save time, money for clients with early-stage biologics

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs